Megacaps are the best in the pharmaceutical sector

Within the pharmaceutical sector, we see a low diversification of the 12-months returns. Since January last year the sector is around 17 percent lower. Among the winners we find ProQR Therapeutics NV, Amarinoration and BioArctic AB. Relatively big losses were for Faron Pharmaceuticals Oy, ImmuPharma and Genomic Vision SA.

Core figures pharmaceutical sector

stock prices

The megacaps in this sector are the winners. Among the less performing are mostly the microcaps.

Lowest PE-ratios pharmaceutical sector

equity research

Regarding the price/earnings-ratios we see a spread palette. The large caps are with the price/earnings-ratio of 24 the most expensive. The smallcaps are the cheapest and trade at -6 times the earnings per share. Benchmark Holdings, Oxford BioMedica and Abcam are the stocks with the highest ratios. Stocks with the lowest ratios are Mallinckrodt, Endo International and Lannett Company.

Highest dividend yields pharmaceutical sector

financial analysis

The sector's average dividend yield is with 0,6 percent relatively limited. Stocks now high dividend yields now are Biotoscana Investments SA, Orion and AbbVie.

This is a free publication from Valuespectrum Pro. Valuespectrum Pro is a professional platform with analyses from all US and European companies. Click here to sign up for free.